- Home
- PROF vs RDIB Comparison
PROF vs RDIB Comparison
Compare PROF & RDIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROF
- RDIB
- Stock Information
- Founded
- PROF N/A
- RDIB 1937
- Country
- PROF Canada
- RDIB United States
- Employees
- PROF N/A
- RDIB N/A
- Industry
- PROF Medical/Dental Instruments
- RDIB Movies/Entertainment
- Sector
- PROF Health Care
- RDIB Consumer Discretionary
- Exchange
- PROF Nasdaq
- RDIB Nasdaq
- Market Cap
- PROF 149.7M
- RDIB 140.2M
- IPO Year
- PROF N/A
- RDIB N/A
- Fundamental
- Price
- PROF $5.86
- RDIB $10.62
- Analyst Decision
- PROF Strong Buy
- RDIB
- Analyst Count
- PROF 1
- RDIB 0
- Target Price
- PROF $11.00
- RDIB N/A
- AVG Volume (30 Days)
- PROF 34.8K
- RDIB 13.7K
- Earning Date
- PROF 08-07-2025
- RDIB 08-13-2025
- Dividend Yield
- PROF N/A
- RDIB N/A
- EPS Growth
- PROF N/A
- RDIB N/A
- EPS
- PROF N/A
- RDIB N/A
- Revenue
- PROF $11,862,000.00
- RDIB $205,644,000.00
- Revenue This Year
- PROF $71.17
- RDIB $7.47
- Revenue Next Year
- PROF $134.25
- RDIB $13.22
- P/E Ratio
- PROF N/A
- RDIB N/A
- Revenue Growth
- PROF 75.01
- RDIB N/A
- 52 Week Low
- PROF $3.90
- RDIB $5.78
- 52 Week High
- PROF $11.42
- RDIB $21.34
- Technical
- Relative Strength Index (RSI)
- PROF 47.74
- RDIB 49.83
- Support Level
- PROF $5.54
- RDIB $8.91
- Resistance Level
- PROF $5.87
- RDIB $10.75
- Average True Range (ATR)
- PROF 0.25
- RDIB 0.64
- MACD
- PROF -0.04
- RDIB -0.05
- Stochastic Oscillator
- PROF 33.09
- RDIB 38.47
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
About RDIB Reading International Inc Class B
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.